IQGAP1 and arteriosclerosis: These findings provide novel insight into IQGAP1 as a potential therapeutic target for inflammation- and angiogenesis-dependent ischemic diseases including peripheral vascular disease, arteriosclerosis, and wound healing, as well as tumor progression.